Biocept Stock

Biocept Revenue

The The revenue of Biocept (BIOCQ) as of Mar 6, 2026 is 22.12 M USD. In the previous year, The revenue was 6.67 M USD — a change of 231.83% (higher).

Revenue

22.12 MUSD

YoY

231.83%

Last updated: Mar 6, 2026

In 2026, Biocept's sales reached 22.12 M USD, a 231.83% difference from the 6.67 M USD sales recorded in the previous year.

The Biocept Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M USD)
GROSS MARGIN (%)
Date
REVENUE (M USD)
GROSS MARGIN (%)
Jan 1, 2011
0 base
0 base
Jan 1, 2012
0.11 base
-99,091 base
Jan 1, 2013
0.13 base
-169,231 base
Jan 1, 2014
0.13 base
-156,923 base
Jan 1, 2015
0.61 base
-65,410 base
Jan 1, 2016
3.22 base
-11,491 base
Jan 1, 2017
5.07 base
-8,442 base
Jan 1, 2018
3.25 base
-20,923 base
Jan 1, 2019
5.53 base
-9,855 base
Jan 1, 2020
27.46 base
2,229 base
Jan 1, 2021
61.25 base
3,835 base
Jan 1, 2022
25.86 base
-998 base
Invalid Date
2.55 base
-10,118 base
Invalid Date
6.67 base
-3,870 base
Invalid Date
22.12 base
-1,166 base
YEARREVENUE (M USD)GROSS MARGIN (%)
2025 est 22.12-11,66
2024 est 6.67-38,70
2023 est 2.55-101,18
2022 25.86-9,98
2021 61.2538,35
2020 27.4622,29
2019 5.53-98,55
2018 3.25-209,23
2017 5.07-84,42
2016 3.22-114,91
2015 0.61-654,10
2014 0.13-1569,23
2013 0.13-1692,31
2012 0.11-990,91
2011 --

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Biocept Revenue

Biocept Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
0 USD
-12.27 M USD
-13.63 M USD
Jan 1, 2012
110,000 USD
-10.5 M USD
-12.26 M USD
Jan 1, 2013
130,000 USD
-7.94 M USD
-9.23 M USD
Jan 1, 2014
130,000 USD
-13.87 M USD
-15.87 M USD
Jan 1, 2015
610,000 USD
-16.41 M USD
-16.95 M USD
Jan 1, 2016
3.22 M USD
-18.03 M USD
-18.4 M USD
Jan 1, 2017
5.07 M USD
-21.17 M USD
-21.61 M USD
Jan 1, 2018
3.25 M USD
-24.26 M USD
-25.21 M USD
Jan 1, 2019
5.53 M USD
-23.06 M USD
-25.26 M USD
Jan 1, 2020
27.46 M USD
-15.47 M USD
-17.81 M USD
Jan 1, 2021
61.25 M USD
-2.41 M USD
-2.82 M USD
Jan 1, 2022
25.86 M USD
-31.98 M USD
-32.09 M USD
Invalid Date
2.55 M USD
-24.68 M USD
-3.26 M USD
Invalid Date
6.67 M USD
-23.76 M USD
-810,197.95 USD
Invalid Date
22.12 M USD
-17.44 M USD
-499,035 USD

Biocept Margins

Biocept stock margins

The Biocept margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biocept. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biocept.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
-9.98 %
0 %
0 %
Jan 1, 2012
-990.91 %
-9,545.45 %
-11,145.46 %
Jan 1, 2013
-1,692.31 %
-6,107.69 %
-7,100 %
Jan 1, 2014
-1,569.23 %
-10,669.23 %
-12,207.69 %
Jan 1, 2015
-654.1 %
-2,690.16 %
-2,778.69 %
Jan 1, 2016
-114.91 %
-559.94 %
-571.43 %
Jan 1, 2017
-84.42 %
-417.55 %
-426.23 %
Jan 1, 2018
-209.23 %
-746.46 %
-775.69 %
Jan 1, 2019
-98.55 %
-417 %
-456.78 %
Jan 1, 2020
22.29 %
-56.34 %
-64.86 %
Jan 1, 2021
38.35 %
-3.93 %
-4.6 %
Jan 1, 2022
-9.98 %
-123.67 %
-124.09 %
Invalid Date
-9.98 %
-967.76 %
-127.78 %
Invalid Date
-9.98 %
-356.37 %
-12.15 %
Invalid Date
-9.98 %
-78.84 %
-2.26 %

Biocept Stock analysis

What does Biocept do? Biocept is one of the most popular companies on Eulerpool.com.

Revenue Details

Understanding Biocept's Sales Figures

The sales figures of Biocept originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Biocept’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Biocept's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Biocept’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Biocept stock

The revenue of Biocept amounted to 6.67 M USD 22.12 M

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Income Statement — Biocept

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Biocept